Dear Editor, Severe hypoxia is detrimental during critical illness, but hyperoxia has also been associated with adverse outcomes [1] [2] [3] . Harm from hyperoxia may be a biological consequence of oxidative damage or reflect iatrogenic injury resulting from more aggressive care. ARDSnet protocols include conservative oxygenation targets (arterial oxygen saturation (SpO 2 ) 88-95%) [4] in recognition of the fact that the harms of high inspired oxygen fractions (FiO 2 ) and ventilation volumes and pressures may outweigh any advantage of an additional buffer against hypoxia.
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Where does this balance of harm and benefit of oxygenation lie on the paediatric intensive care unit (PICU)? As part of preliminary work towards our Oxy-PICU trial for conservative versus liberal oxygenation targets, we investigated current practice at a large general PICU over 12 months. Children were selected on the basis of a measured actual oxygen content in arterial blood (PaO 2 ):FiO 2 ratio (PF) of <300 mmHg (8217 values in 326 children). This criterion excluded children likely to have high SpO 2 values without supplemental oxygen or ventilator support. We analysed SpO 2 data at 5-s intervals in the 1 h before and after 5096 PF values of <300 mmHg from 227 children with available data: a total of 7,352,388 SpO 2 values were collected using the Etiometry T3 system (Etiometry Inc., Allston, MA). Concurrent hourly FiO 2 and mean airway pressure (MAP) data were collected from the electronic health record. SpO 2 data were analysed in four groups based on a FiO 2 of ≥ or <0.6, and a MAP of ≥ or <16 cmH 2 O in the hour of measurement. The SpO 2 distributions were compared using the Kolmogorov-Smirnov test. A multi-level linear regression model was used to test whether the SpO 2 (dependent variable), FiO 2 and MAP (as categorical fixed effect variables) relationship was skewed by individual patients (random effects variable). Any crude mortality effect of oxygenation was sought by comparing the mean SpO 2 value over the first 48 h of admission according to survival status at discharge. All data were processed using Microsoft Excel (Microsoft Corp., Redmond, WA) and R (http://www.rcran.org).
The distribution of SpO 2 values are shown in Fig. 1 . In all four combinations of FiO 2 and MAP, 99-100% was the modal SpO 2 ; 26.4% of all SpO 2 values were 99 or 100%, and 70.8% were >95%. Each of the four distributions were significantly different to each other (KolmogorovSmirnov p < 0.001), with the greatest difference observed between high and low FiO 2 groups. The multi-level regression model confirmed that high FiO 2 was associated with lower SpO 2 regardless of individual patients. There were no significant differences between the 48-h mean SpO 2 values in those who died or survived (see Electronic Supplementary Material).
These data demonstrate (1) current practice is for very liberal oxygenation above the recommended targets even in children with low PF ratios; (2) children receiving higher treatment levels (FiO 2 ≥0.6, MAP >16 cmH 2 O) have a slightly lower SpO 2 distribution, an effect more pronounced with high FiO 2 than with high MAP.
These high-resolution data demonstrate that PICU practice does not follow what clinicians report [5] , recent evidence [3] or existing guidelines [4] . A pragmatic clinical trial of oxygenation targets in critically ill children is necessary, and can reasonably include a control group with >94% SpO 2 to reflect current practice.
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